Sangamo Therapeutics

$6.33

+$0.52 (+8.93%) Today
-$0.01 (-0.16%) As of 11:59 PM UTC after-hours
1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.

About SGMO

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases. 

CEO
Alexander D. Macrae
CEOAlexander D. Macrae
Employees
431
Employees431
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
1995
Founded1995
Employees
431
Employees431

SGMO Key Statistics

Market cap
930.00M
Market cap930.00M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.75M
Average volume1.75M
High today
$6.39
High today$6.39
Low today
$5.77
Low today$5.77
Open price
$5.77
Open price$5.77
Volume
1.47M
Volume1.47M
52 Week high
$11.49
52 Week high$11.49
52 Week low
$3.12
52 Week low$3.12

Analyst ratings

73%

of 11 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

SGMO Earnings

-$0.35
-$0.30
-$0.26
-$0.21
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
-$0.35 per share
Estimated-$0.35 per share
Actual
-$0.29 per share
Actual-$0.29 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.